Correction to: A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder, by Strawn et al. J Child Adolesc Psychopharmacol 2023;33(3):91–100; doi: 10.1089/cap.2023.0004

Abstract

Journal of Child and Adolescent PsychopharmacologyVol. 33, No. 5 CorrectionOpen AccessCorrection to: A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder, by Strawn et al. J Child Adolesc Psychopharmacol 2023;33(3):91–100; doi: 10.1089/cap.2023.0004is erratum ofA Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety DisorderPublished Online:16 Jun 2023https://doi.org/10.1089/cap.2023.0004.correxAboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail In the April 2023 issue of Journal of Child and Adolescent Psychopharmacology (vol. 33, no. 3; pp. 91–100) the article entitled “A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder” by Strawn et al. requires correction.This article was originally published under the copyright of Mary Ann Liebert, Inc. publishers. It has now been updated to reflect Open Access, with copyright transferring to the author(s), and a Creative Commons License (CC-BY) added (http://creativecommons.org/licenses/by/4.0). The CC-BY license goes into effect May 26, 2023.The online version of this article has been corrected to reflect this.FiguresReferencesRelatedDetailsRelated articlesA Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder17 Apr 2023Journal of Child and Adolescent Psychopharmacology Volume 33Issue 5Jun 2023 InformationCopyright 2023, Mary Ann Liebert, Inc., publishersTo cite this article:Correction to: A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder, by Strawn et al. J Child Adolesc Psychopharmacol 2023;33(3):91–100; doi: 10.1089/cap.2023.0004.Journal of Child and Adolescent Psychopharmacology.Jun 2023.200-200.http://doi.org/10.1089/cap.2023.0004.correxcreative commons licensePublished in Volume: 33 Issue 5: June 16, 2023PDF download